Compare WAL & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAL | TXG |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.3B |
| IPO Year | 2005 | 2019 |
| Metric | WAL | TXG |
|---|---|---|
| Price | $76.03 | $69.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 18 |
| Target Price | ★ $89.69 | $77.50 |
| AVG Volume (30 Days) | 1.1M | ★ 3.7M |
| Earning Date | 10-19-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | 23.13 | ★ 76.97 |
| EPS | ★ 3.99 | N/A |
| Revenue | $135,800,000.00 | ★ $245,893,000.00 |
| Revenue This Year | $12.64 | N/A |
| Revenue Next Year | $4.37 | $10.11 |
| P/E Ratio | $19.41 | ★ N/A |
| Revenue Growth | ★ 99.71 | 68.06 |
| 52 Week Low | $65.82 | $12.80 |
| 52 Week High | $97.23 | $102.81 |
| Indicator | WAL | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 49.38 | 43.85 |
| Support Level | $73.93 | $67.25 |
| Resistance Level | $84.75 | $102.81 |
| Average True Range (ATR) | 2.00 | 5.98 |
| MACD | 0.35 | -0.15 |
| Stochastic Oscillator | 69.18 | 9.65 |
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).